Debra M. Imhoff
Impact in
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Analytical Methods in Pharmaceuticals 7
-
- Pharmacogenetics and Drug Metabolism 4
- Inflammatory mediators and NSAID effects 2
- Co-authors
- Felix Bochner (13 shared papers)Bill E. Cham (4 shared papers)Lesley Ross-Lee (2 shared papers)Malcolm Rowland (1 shared paper)David Siebert (1 shared paper)J. V. Lloyd (1 shared paper)Garry G. Graham (2 shared papers)D. J. C. Shearman (2 shared papers)
- Journals
- Therapeutic Drug Monitoring (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Clinical Chemistry (2 papers)European Journal of Clinical Pharmacology (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- Australia
In The Last Decade
Debra M. Imhoff
13 papers receiving 348 citations
Peers
Comparison fields: 5 of 77
- Analytical Chemistry 97
- Pharmacology 72
- Pharmacology 109
- Cardiology and Cardiovascular Medicine 62
- Internal Medicine 9
Countries citing papers authored by Debra M. Imhoff
This map shows the geographic impact of Debra M. Imhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra M. Imhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra M. Imhoff more than expected).
Fields of papers citing papers by Debra M. Imhoff
This network shows the impact of papers produced by Debra M. Imhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra M. Imhoff. The network helps show where Debra M. Imhoff may publish in the future.
Co-authors
The 20 scholars most cited alongside Debra M. Imhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 69 | |
| 2 | 1980 | 62 | |
| 3 | 1983 | 59 | |
| 4 | 1980 | 37 | |
| 5 | 1981 | 32 | |
| 6 | 1986 | 27 | |
| 7 | 1988 | 26 | |
| 8 | Plasma and synovial fluid gentisate in patients receiving salicylate therapy. | 1985 | 15 |
| 9 | 1980 | 14 | |
| 10 | 1984 | 12 | |
| 11 | 1987 | 10 | |
| 12 | 1986 | 5 | |
| 13 | 1982 | 4 |
About Debra M. Imhoff
Debra M. Imhoff is a scholar working on Analytical Chemistry, Pharmacology, Spectroscopy, Pharmacology and Surgery, having authored 13 papers that have together received 372 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (7 papers), Pharmacogenetics and Drug Metabolism (4 papers), Analytical Chemistry and Chromatography (4 papers), Inflammatory mediators and NSAID effects (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Microscopic Colitis (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Analytical Chemistry (97 citations), Pharmacology (72 citations), Pharmacology (109 citations), Cardiology and Cardiovascular Medicine (62 citations) and Internal Medicine (9 citations). Debra M. Imhoff has collaborated with scholars based in Australia. Frequent co-authors include Felix Bochner, Bill E. Cham, Lesley Ross-Lee, Malcolm Rowland, David Siebert, J. V. Lloyd, Garry G. Graham, D. J. C. Shearman, R. Rowland and David J. Hetzel. Their work appears in journals such as Therapeutic Drug Monitoring, Clinical Pharmacology & Therapeutics, Clinical Chemistry, European Journal of Clinical Pharmacology and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.